Amarantus Bioscience Holdings Inc (AMBS)

[Voices of Reason]

Suppose they get enough interest to fund the clinical trials - at what toxic debt conversion rate would be acceptable to consummate the funding at without further killing the company?

It's a rhetorical question of course....in my opinion, the best outcome for AMBS is to liquidate their technology to settle open and pending lawsuits (or to someone that has the means to bring it to fruition), then sell what remains of the shell.